BioXcel Therapeutics, Inc. (BTAI)

BioXcel Therapeutics Revenue

In the year 2024, BioXcel Therapeutics had annual revenue of $2.27M with 64.20% growth. BioXcel Therapeutics had revenue of $366.00K in the quarter ending December 31, 2024, a decrease of -2.66%.

• Revenue (ttm): $2.27M
• Revenue Growth: +64.20%
• P/S Ratio: 2.09
• Revenue / Employee: $61,243
• Employees: 37
• Market Cap: 10.72M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.27M	886.00K	64.20%
Dec 31, 2023	1.38M	1.01M	268.00%
Dec 31, 2022	375.00K	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.